OurCrowd Portfolio Company SaNOtize Moves Forward with Anti-COVID Nitric Oxide Nasal Spray, Approved for Sale
OurCrowd portfolio company SaNOtize Research & Development Corp. has received interim approval to sell its COVID-19 treatment Nitric Oxide Nasal Spray (NONS). The spray is said to protect users from viruses that enter the body through the upper nasal pathways. The spray will be sold… Read More
Read more in: General News, Investment Platforms and Marketplaces, Offerings | Tagged chris miller, covid-19, gilly regev, israel, ourcrowd, sanotize